Light Mode
$1.73 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.73, $0.13 below the day’s high of $1.86
+0.61 (+54.46%) / 6M
Momentum, market sentiment, and recent alerts
OPK reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +29.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment manages the clinical laboratory operations of BioReference. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and their global pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.